Partnered Solutions for the Next Generation of Multi-Disciplinary Healthcare
The healthcare marketplace is changing at an incredible rate both in Europe and around the world. Due to intensifying pressure, healthcare systems need to deliver more for less whilst still meeting the ‘triple aim’ of improving outcomes, increasing patient satisfaction, and reducing costs.
Johnson & Johnson Medical Devices (JJMD) recognized this shift in focus from volume to value and, using more than 130 years of knowledge and expertise, they proudly launched their new CareAdvantage approach across Europe, Middle East and Africa (EMEA) in June 2017. The primary objective of this new approach is to co-create measurable programs that can result in rapid transformation for hospital systems, clinicians, and their patients.
CareAdvantage is a data-driven, holistic approach that starts with listening. Strategic priorities are identified through a structured on-site assessment, using performance data and insights. The approach is designed to help drive clinical and economic value-based healthcare solutions through establishing partnerships with hospitals and other healthcare providers. Through working collaboratively, CareAdvantage can offer a range of benefits, tailored to specific needs and priorities. Based on agreed metrics for outcomes and a clear roadmap for delivery, co-created programs are rolled out within hospitals that can deliver remarkable value at every stage of the care pathway.
CareAdvantage is focused on four key areas
CareAdvantage is a true reflection of what inspires and unites all Johnson & Johnson Companies: caring for the world, one person at a time. With the companies already touching over a billion lives around the world, JJMD’s new CareAdvantage approach defines the next generation of multi-disciplinary healthcare solutions which further encourage partnership working to reach even more lives around the world.